Chaoyang Sun - Concepedia

Author

Chaoyang Sun

Also Known As

C Sun, C. -C. Sun, C. Sun, CHAOYANG SUN, Chao-Yang Sun, ChaoYang Sun, Chaoyang SUN, Chaoyang Sun, Cheng-Yong Sun, Chongbao Sun

220

Publications

4.7K

Citations

H-Index

Concepts

All Affiliations

Tongji Hospital Huazhong University of Science and Technology Oregon Health & Science University The University of Texas MD Anderson Cancer Center Wuhan University

About

Chaoyang Sun is an author at Tongji Hospital specializing in medicine, ovarian cancer, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	20	1.3K
2	Engineering	4	4	387
3	Public Health	4	4	237
4	Health Sciences	2	2	54
5	Language Studies	1	1	20

Chaoyang Sun

Publications

Citations

H-Index

Page 1

	Year	Citations
BRD4 Inhibition Is Synthetic Lethal with PARP Inhibitors through the Induction of Homologous Recombination Deficiency Chaoyang Sun, Jun‐Jie Yin, Yong Fang, Cancer Cell Homologous Recombination DeficiencyEngineeringMolecular BiologySynthetic BiologyRecombination Dynamic	2018	295
Heterotypic CAF-tumor spheroids promote early peritoneal metastasis of ovarian cancer Qinglei Gao, Zongyuan Yang, Sen Xu, The Journal of Experimental Medicine	2019	248
Sequential Therapy with PARP and WEE1 Inhibitors Minimizes Toxicity while Maintaining Efficacy Yong Fang, Daniel J. McGrail, Chaoyang Sun, Cancer Cell Clinical TherapeuticMedicinePharmacotherapyPharmacologyNovel Therapy	2019	231
Cancer history is an independent risk factor for mortality in hospitalized COVID-19 patients: a propensity score-matched analysis Yifan Meng, Wanrong Lu, Ensong Guo, Journal of Hematology & Oncology	2020	193
miR-9 Regulation of BRCA1 and Ovarian Cancer Sensitivity to Cisplatin and PARP Inhibition Chaoyang Sun, Na Li, Zongyuan Yang, JNCI Journal of the National Cancer Institute	2013	169
The biodiversity Composition of Microbiome in Ovarian Carcinoma Patients Bo Zhou, Chaoyang Sun, Jia Huang, Scientific Reports Microbial DiversityMicrobial SystematicsDysbiosisPathologyGynecology	2019	139
The trans-omics landscape of COVID-19 Peng Wu, Dongsheng Chen, Wencheng Ding, Nature Communications Virus EpidemiologyImmunologyCovid-19 EpidemiologyImmune DysregulationCovid-19	2021	133
Cisplatin-induced CCL5 secretion from CAFs promotes cisplatin-resistance in ovarian cancer via regulation of the STAT3 and PI3K/Akt signaling pathways Bo Zhou, Chaoyang Sun, Na Li, International Journal of Oncology Cisplatin-induced Ccl5 SecretionGynecologyPi3k/akt Signaling PathwaysCancer BiologyTumor Biology	2016	108
Proteome Instability Is a Therapeutic Vulnerability in Mismatch Repair-Deficient Cancer Daniel J. McGrail, Jeannine Garnett, Jun‐Jie Yin, Cancer Cell Genome InstabilityMedicinePathologyProteome InstabilityTumor Suppressor	2020	108
Metformin Suppresses Tumor Progression by Inactivating Stromal Fibroblasts in Ovarian Cancer Sen Xu, Zongyuan Yang, Ping Jin, Molecular Cancer Therapeutics	2018	92

Page 1